Biomarkers and therapeutic targets in early Alzheimer’s disease: an Olink proteomics study

Biomarkers and therapeutic targets in early Alzheimer’s disease: an Olink proteomics study

PurposeThis study aims to analyze differential expression of inflammation-related proteins in plasma from patients with mild cognitive impairment (MCI) and early-stage Alzheimer’s disease (AD), for exploring potential biomarkers and therapeutic targets for AD, providing new possibilities for the ear...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jianan Wei, Hui Ni, Weiwei Liu, Hui Xu, Chen Wang, Geng Geng, Zhongwei He, Guofang Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Neurology
Subjects:	Alzheimer’s disease dementia biomarkers Olink proteomics inflammation
Online Access:	https://www.frontiersin.org/articles/10.3389/fneur.2025.1615152/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cerebrospinal fluid protein profiling of inflammatory and neurobiological markers in Lyme neuroborreliosis
by: Sofie Haglund, et al.
Published: (2025-06-01)

Protein quantitative trait locus analysis in African American and non-Hispanic White individuals
by: Yanwei Cai, et al.
Published: (2025-07-01)

Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease
by: Jakob M Bader, et al.
Published: (2020-06-01)

Sex differences in proteomics of cardiovascular disease – Results from the Yale-CMD registry
by: Yihan Liu, et al.
Published: (2025-06-01)

The Link Between Periodontal Disease and Alzheimer's Disease: a narrative review
by: Kamila Geborys, et al.
Published: (2025-05-01)

Altered co-expression patterns of synovial fluid proteins related to the immune system and extracellular matrix organization in late stage OA, compared to non-OA controls
by: Jenny Lönsjö, et al.
Published: (2025-06-01)

Alzheimer’s disease in family practice
by: Oppel B.W. Greeff
Published: (2009-10-01)

Strategies for Treating Alzheimer’s: Current Approaches and Future Perspectives
by: Adriana Skuba, et al.
Published: (2025-05-01)

Understanding Alzheimer disease
by: M. Vally, et al.
Published: (2019-04-01)

Toward Identification of Markers for Brain‐Derived Extracellular Vesicles in Cerebrospinal Fluid: A Large‐Scale, Unbiased Analysis Using Proximity Extension Assays
by: Maia Norman, et al.
Published: (2025-03-01)

Bioinformatics and experimental validation identify biomarkers for diagnosing Alzheimer’s disease
by: Hui Liu, et al.
Published: (2025-08-01)

Non-invasive urinary proteomic biomarkers for prognostic assessment in sepsis
by: Qingbo Zeng, et al.
Published: (2025-07-01)

Revisiting biomarker discovery by plasma proteomics
by: Philipp E Geyer, et al.
Published: (2017-09-01)

Chitinase‐3‐Like 1 Protein (CHI3L1) Levels in Patients With Cognitive Deficits and Movement Disorders: Comparison With Other Biomarkers
by: R. Novobilský, et al.
Published: (2025-06-01)

Early emergence of motivational and hedonic feeding deficits in the TgF344-AD rat model of Alzheimer’s disease
by: Sean B. Ostlund, et al.
Published: (2025-04-01)

Preclinical development of an immunoassay for the detection of TREM2: a new biomarker for Alzheimer’s disease
by: Jie Hu, et al.
Published: (2025-07-01)

The proteomics in prostate cancer biomarker discovery
by: V. E. Shevchenko, et al.
Published: (2015-06-01)

Immune cells in Alzheimer’s disease: insights into pathogenesis and potential therapeutic targets
by: Fu Xiaofeng, et al.
Published: (2024-12-01)

Oxidative stress and metabolic syndrome in Alzheimer’s disease: the search for a relationship
by: N. M. Zalutskaya, et al.
Published: (2024-12-01)

Proteome-wide association studies using summary pQTL data of brain, CSF, and plasma identify 30 risk genes of Alzheimer’s disease dementia
by: Tingyang Hu, et al.
Published: (2025-06-01)

Proteomics on choroidal neovascularization based on itraq and the protective effect of TAB1 in CNV
by: Yong Du, et al.
Published: (2025-08-01)

Quantitative proteomics unveils potential plasma biomarkers and provides insights into the pathophysiological mechanisms underlying equine metabolic syndrome
by: E. M. Espinosa-López, et al.
Published: (2025-07-01)

Lithium and neuroprotection: a review of molecular targets and biological effects at subtherapeutic concentrations in preclinical models of Alzheimer’s disease
by: Vanessa de Jesus R. De-Paula, et al.
Published: (2025-05-01)

Stem cell-based therapeutic strategies for down syndrome and Alzheimer’s disease
by: Osama Hamadelseed, et al.
Published: (2025-08-01)

Trends and forecasts of the prevalence and mortality of Alzheimer’s disease and other dementias in China
by: Mingxuan Hou, et al.
Published: (2025-07-01)

Mapping the hippocampal spatial proteomic signature in male and female mice of an early Alzheimer’s disease model
by: Ana Contreras, et al.
Published: (2025-05-01)

Association between the DASH diet and Alzheimer’s disease in a case-control study
by: Mohammad Mehdi Abbasi, et al.
Published: (2025-07-01)

Association between neuroinflammation, vascular risk, and biomarkers in Alzheimer’s disease
by: CHEN Yanming, HU Heying, CUI Ruiping, HU Hao, TAN Chenchen, TAN Lan
Published: (2025-08-01)

Plasma Proteome Profiling to detect and avoid sample‐related biases in biomarker studies
by: Philipp E Geyer, et al.
Published: (2019-09-01)

Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
by: Sebastian Palmqvist, et al.
Published: (2019-11-01)

Discovery of potential ovarian cancer biomarkers using low molecular weight blood plasma proteome profiling by mass spectrometry
by: V. E. Shevchenko, et al.
Published: (2014-07-01)

“It may just be aging”: illness representations of Brazilians with Alzheimer’s disease
by: Paula Gasparini Emery Trindade, et al.
Published: (2025-08-01)

Immunoassay for pyruvate kinase M1/2 as an Alzheimer’s biomarker in CSF
by: de Geus Matthijs B., et al.
Published: (2025-07-01)

Metabolic syndrome and risk of incident all-cause dementia, Alzheimer’s disease and vascular dementia: a systematic review and meta-analysis of longitudinal studies
by: Danial Qureshi, et al.
Published: (2025-08-01)

Comorbidities predict institutionalization and mortality in biomarker-confirmed alzheimer’s disease
by: Xin Xia, et al.
Published: (2025-07-01)

Glutamate-cysteine ligase as a diagnostic biomarker and therapeutic target in Parkinson's disease: a multi-omics and experimental study
by: Xuzhao Li, et al.
Published: (2025-08-01)

P‐tau235: a novel biomarker for staging preclinical Alzheimer’s disease
by: Juan Lantero‐Rodriguez, et al.
Published: (2021-11-01)

Case Report: The Alzheimer’s paradox: a clinically stable amnestic syndrome with full biomarker positivity and minimal imaging evidence
by: Anna-Chloé Balageas, et al.
Published: (2025-08-01)

Proteomic Profiling Reveals TPR and FGA as Predictive Serum Biomarkers of Relapse to First- and Second-Generation EGFR-TKIs in Advanced Lung Adenocarcinoma
by: Pritsana Raungrut, et al.
Published: (2025-06-01)

The Role of Diet, Physical Activity, and Lifestyle in Alzheimer's Disease Prevention: A Literature Review
by: Adrianna Bogucka, et al.
Published: (2025-05-01)